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Background: The SYNTAX score (SXscore) has been shown to be an effective predictor of clinical outcomes in patients with multivessel disease 
undergoing percutaneous coronary intervention (PCI).
Objective: We aimed at assessing the predictive value of the SXscore for major adverse cardiac events in the “all-comers” population of the 
LEADERS trial.
Methods: The SXscore was prospectively collected in 1,397 of the 1,707 patients enrolled in the LEADERS trial (patients after surgical 
revascularization were excluded). Post-hoc analysis was performed by stratifying clinical outcomes at 1 year follow-up, according to one of three 
SYNTAX score tertiles.
Results: 1,397 patients were divided into tertiles based on the SYNTAX score in the following fashion: SXlow <=8 (n=464), 8 <SXmid <=16 
(n=472) and SXhigh >16 (n=461).
At 1 year follow-up there was a significantly lower number of patients with MACE-free survival in the highest tertile of SX score (SXlow=91.6%, 
SXmid=91.1% and SXhigh=84.6%; p16 (HR 2.39 CI 1.49-3.92; p 16 (HR for Q-wave MI 5.28 CI 1.35-20.67; p=0.017). Clinically driven TVR was 
8.5% in the SXhigh group versus 4.8% and 5.5% in the SXlow and SXmid groups, respectively (HR 2.22; CI 1.22-3.94; p=0.008). The rate of definite 
early stent thrombosis was 0.9%, 2.1% and 3.5% in the SXlow, SXmid and SXhigh, respectively (HR 1.66; p=0.051). The rate of definite late stent 
thrombosis (30 days-1 year) was 0%, 0.2% and 0.9% in the SXlow, SXmid and SXhigh tertiles(HR=5.83; p=0.07).
Conclusions: The SYNTAX score when applied to an all-comers patient population may allow for prospective risk stratification of patients 
undergoing PCI.
